Paper4831442
Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by several sulfur-containing compounds.
Wattenberg LW. J Natl Cancer Inst, 1974. Cited by 104 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by several sulfur-containing compounds. Papers, record 4831442. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4831442
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by several sulfur-containing compounds.
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benz(a)Anthracenes | Major topic |
| Benzopyrenes | Major topic |
| Disulfiram | Major topic |
| Neoplasms, Experimental | Major topic |
| Thiocarbamates | Major topic |
| Thiocyanates | Major topic |
| Adenoma | |
| Administration, Oral | |
| Adrenal Glands | |
| Aldehyde Oxidoreductases | |
| Animals | |
| Benzyl Compounds | |
| Diet | |
| Female | |
| Intestines | |
| Intubation | |
| Liver | |
| Lung Neoplasms | |
| Mammary Neoplasms, Experimental | |
| Mice | |
| Mice, Inbred A | |
| Mice, Inbred ICR | |
| Rats | |
| Stomach | |
| Stomach Neoplasms |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42737566 | Repurposing Disulfiram for Cancer Therapy: Mechanistic Insights and Translational Challenges. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737566 | PubMed |
| 40341098 | The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40341098 | PubMed |
| 34102289 | Targeting NRF2 to treat cancer. | Semin Cancer Biol | 2021 | https://conductscience.org/library/papers/34102289 | PubMed |
| 33276631 | NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33276631 | PubMed |
| 32400766 | The role of natural products in revealing NRF2 function. | Nat Prod Rep | 2020 | https://conductscience.org/library/papers/32400766 | PubMed |
| 25383193 | Anticancer activity and chemoprevention of xenobiotic organosulfurs in preclinical model systems. | Oncol Discov | 2013 | https://conductscience.org/library/papers/25383193 | PubMed |
| 9255587 | Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke. | Environ Health Perspect | 1997 | https://conductscience.org/library/papers/9255587 | PubMed |
| 4608703 | Potential inhibitors of colon carcinogenesis. | Am J Dig Dis | 1974 | https://conductscience.org/library/papers/4608703 | PubMed |
| 620719 | The mitigating effect of dietary antioxidants on chemically-induced carcinogenesis. | Experientia | 1978 | https://conductscience.org/library/papers/620719 | PubMed |
| 612437 | Effect of various treatments on toxicity of inhaled vinylidene chloride. | Environ Health Perspect | 1977 | https://conductscience.org/library/papers/612437 | PubMed |
| 454558 | Differential effects of antioxidants, steroids and other compounds on benzo(a)pyrene 3-hydroxylase activity in various tissues of rat. | Br J Cancer | 1979 | https://conductscience.org/library/papers/454558 | PubMed |
| 328015 | The effects of antioxidants on the metabolism and mutagenicity of benzo[a]pyrene in vitro. | Biochem J | 1977 | https://conductscience.org/library/papers/328015 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4831442
GET https://conductscience.org/api/papers/v1/4831442/authors